Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal cord injured, multiple sclerosis, and similar patient populations.

Pharmaceutical

Dignify Therapeutics

Dignify Therapeutics' headquarters in Durham, NC, United States

Ed Burgard

Karl Thor

Bradley P. Kropp

Michael J. Kennelly

Gary M. Mawe

Marcalee Alexander

Michael Camilleri

Kristy M. Borawski

Mike Jay

The Leadership Team at Dignify Therapeutics is responsible for setting the strategic direction of the company, driving innovation in drug development, and overseeing the integration of scientific research with clinical application. Comprising senior executives with expertise in chemistry, preclinical research, and drug development, they collaborate to advance novel therapies targeting bladder and bowel disorders, ensuring alignment with the company's mission to improve outcomes for patients with spinal cord injuries and multiple sclerosis.

Leadership Team

The Research and Development team at Dignify Therapeutics is dedicated to advancing innovative drug therapies for bladder and bowel disorders. Comprising experts in chemistry, drug development, preclinical research, and overall scientific strategy, the team collaborates to design, evaluate, and optimize new therapeutic candidates, ensuring they meet the specific needs of patients with spinal cord injuries and related conditions.

Dignify Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Offices

Dignify Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Offices

Related companies